No AI summary for this filing type
View Full Filing (SEC EDGAR)Monopar Therapeutics INC
-$19.3M
Net Activity
Institutions Holding
81
Popularity Rank
#4928
Avg Weight
0.10%
Total Value
$341.5M
Ownership Trend
81 institutions currently hold MNPR, with 49 net buyers and 31 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
31
Net Buying Institutions
49
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$169.6M
Total Buy Value
$88.3M
Total Sell Value
49
Net Buyers
31
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
2
Filings (90d)
$962K
Total Est. Value
10K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Arthur Klausner | 2026-07-10 | $477K |
| Arthur Klausner | 2026-07-07 | $485K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding MONOPAR THERAPEUTICS INC (MNPR)?
What is the overall institutional sentiment toward MNPR recently?
Which institutions have been selling or reducing their MNPR positions?
Are there any notable investors adding MNPR to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter